AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

hoover edward

 

Dr. Edward Hoover's laboratory focused for 3 decades on the pathogenesis and intervention for retrovirus infections--in particular feline leukemia virus (FeLV), the feline and simian immunodeficiency viruses (FIV, SIV), and in the most recent decade on the prion disease chronic wasting disease (CWD) of deer and elk.  These infections are important as diseases of animals and as models for cognate human diseases--i.e. leukemia, HIV infection/AIDS, bovine spongiform encephalopathy (mad cow disease, BSE), and Creutzfeld-Jakob, Alzheimer’s, and Parkinson’s diseases.  Research in the Hoover laboratory led to development of the first successful and most widely used FeLV vaccine, now used to immunize cats worldwide against leukemia.  Current work focuses on: (1) the mechanisms trans-mucosal prion infection and excretion; (2) detection of prions in body fluids of live animals; (3) the CWD species barrier in cervid and non-cervid species; and (4) experimental vaccines for prion and protein misfolding diseases.

 

 

TPL_asm2013_SEARCH

91231